產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱(chēng)及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
---|---|---|---|---|---|---|---|
GC39521-100mg |
|
1526718-98-8 |
Bis-PEG6-NHS ester - Glpbio |
0 | 需詢(xún)價(jià) | C24H36N2O14 | |
GC39520-250mg |
|
1310827-27-0 |
Azido-PEG3-SS-PEG3-azide - Glpbio |
0 | 需詢(xún)價(jià) | C16H32N6O6S2 | |
GC39520-100mg |
|
1310827-27-0 |
Azido-PEG3-SS-PEG3-azide - Glpbio |
0 | 需詢(xún)價(jià) | C16H32N6O6S2 | |
GC39519-100mg |
|
— |
m-PEG-NHS ester (MW 5000) - Glpbio |
0 | 需詢(xún)價(jià) | — | |
GC39518-50mg |
|
1198780-38-9 |
β-catenin/CBP-IN-1 - Glpbio |
0 | 需詢(xún)價(jià) | C33H35N6O7P | |
GC39518-10mg |
|
1198780-38-9 |
β-catenin/CBP-IN-1 - Glpbio |
0 | 需詢(xún)價(jià) | C33H35N6O7P | |
GC39518-5mg |
|
1198780-38-9 |
β-catenin/CBP-IN-1 - Glpbio |
0 | 需詢(xún)價(jià) | C33H35N6O7P | |
GC39517-50mg |
|
14293-44-8 |
Xipamide - Glpbio |
0 | 需詢(xún)價(jià) | C15H15ClN2O4S | |
GC39517-10mM (in 1mL DMSO) |
|
14293-44-8 |
Xipamide - Glpbio |
0 | 需詢(xún)價(jià) | C15H15ClN2O4S | |
GC39517-10mg |
|
14293-44-8 |
Xipamide - Glpbio |
0 | 需詢(xún)價(jià) | C15H15ClN2O4S | |
GC39516-100mg |
|
1360540-81-3 |
Wnt pathway activator 1 - Glpbio |
0 | 需詢(xún)價(jià) | C18H16O4 | |
GC39516-50mg |
|
1360540-81-3 |
Wnt pathway activator 1 - Glpbio |
0 | 需詢(xún)價(jià) | C18H16O4 | |
GC39516-10mM (in 1mL DMSO) |
|
1360540-81-3 |
Wnt pathway activator 1 - Glpbio |
0 | 需詢(xún)價(jià) | C18H16O4 | |
GC39516-10mg |
|
1360540-81-3 |
Wnt pathway activator 1 - Glpbio |
0 | 需詢(xún)價(jià) | C18H16O4 | |
GC39515-50mg |
|
— |
TP508 TFA - Glpbio |
0 | 需詢(xún)價(jià) | C99H147N28F3O38S | |
GC39515-10mg |
|
— |
TP508 TFA - Glpbio |
0 | 需詢(xún)價(jià) | C99H147N28F3O38S | |
GC39515-5mg |
|
— |
TP508 TFA - Glpbio |
0 | 需詢(xún)價(jià) | C99H147N28F3O38S | |
GC39514-100mg |
|
1801765-04-7 |
TNO155 - Glpbio |
0 | 需詢(xún)價(jià) | C18H24ClN7OS | |
GC39514-50mg |
|
1801765-04-7 |
TNO155 - Glpbio |
0 | 需詢(xún)價(jià) | C18H24ClN7OS | |
GC39514-25mg |
|
1801765-04-7 |
TNO155 - Glpbio |
0 | 需詢(xún)價(jià) | C18H24ClN7OS | |